Dollarama Inc
SWB:DR3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dollarama Inc
SWB:DR3
|
CA |
|
F
|
Fidelity National Information Services Inc
F:ZGY
|
US |
|
J
|
Johnson & Johnson
F:JNJ
|
US |
|
G
|
Genesco Inc
F:GN8
|
US |
|
P
|
Pernod Ricard SA
SWB:PER
|
FR |
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
|
Reckitt Benckiser Group PLC
OTC:RBGPF
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DR3's stock price target?
Price Target
136.61
EUR
According to Wall Street analysts, the average 1-year price target for
DR3 is 136.61 EUR with a low forecast of 115.14 EUR and a high forecast of 151.09 EUR.
What is the Revenue forecast for Dollarama Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Dollarama Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Dollarama Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 15%.
What is the Pre-Tax Income forecast for Dollarama Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Dollarama Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 8 years is 14%.